Surgical treatment of clinical n1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis

Surgery Today

Volumn 40, Issue 5, 2010, Pages 428-432

  Miyoshi, Kei ^a,b   Mimura, Takeshi ^a,c   Iwanaga, Koichiro ^a   Adachi, Shuji ^a   Tsubota, Noriaki ^a   Okada, Morihito ^a,c  

^a HYOGO CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer; Clinical stage; Lung; Nodal status; Surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77955669809     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-008-4072-4     Document Type: Article

References (16)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
2. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
3. Martini N, Flehinger BJ, Zaman MB, Beattie EJ Jr. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases. J Thorac Cardiovasc Surg 1980;80:390-9.
4. Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension. Cancer 2003;98:535-41.
5. Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, et al. Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg 2005;129:825-30.
6. Hanagiri T, Sugio K, Uramoto H, So T, Ichiki Y, Sugaya M, et al. Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer. Surg Today 2007; 37:546-51.
7. Marra A, Hillejan L, Zaboura G, Fujimoto T, Greschuchna D, Stamatis G. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 2003;125:543-53.
8. Fujimoto T, Cassivi SD, Yang P, Barnes SA, Nichols FC, Deschamps C, et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. J Thorac Cardiovasc Surg 2006;132:499-506.
9. Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Ann Thorac Surg 2005;79:1682-5.
10. World Health Organization. International histological classification of tumours. 2nd ed. Berlin: Springer; 1988.
11. Libshitz HI, McKenna RJ Jr. Mediastinal lymph node size in lung cancer. AJR 1984;143:715-8.
12. Gross BH, Glazer GM, Orringer MB, Spizarny DL, Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and signifi cance. Radiology 1988;166:71-4.
13. Izbicki JR, Thetter O, Karg O, Kreusser T, Passlick B, Trupka A, et al. Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma. J Thorac Cardiovasc Surg 1992;104:413-20.
14. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Evolution of surgical outcomes for nonsmall cell lung cancer: Time trends in 1465 consecutive patients undergoing complete resection. Ann Thorac Surg 2004;77:1926-31.
15. Okada M, Yamagishi H, Satake S, Matsuoka H, Miyamoto Y, Yoshimura M, et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 2000;119:814-9.
16. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Prognostic signifi cance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg 2004;78:216-21.